Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modular hydrogel system with independent control of bioadhesion, fibrosis, and stiffness.

Science advances·2026
Same author

Intracellular delivery of full-length antibodies via organ-targeted lipid nanoparticles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Phosphoserine as an Alternative Energy Source for <i>E. coli</i> Cell-Free Protein Synthesis with Increased Yield and Prolonged Activity.

ACS synthetic biology·2026
Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026
Same author

Wireless battery-free oxygenation devices enable extended immunosuppression-free islet transplantation in minimally invasive sites.

Device·2026
Same author

The long noncoding RNA <i>lnc-FAM164A1</i>-ACLY axis promotes pro-inflammatory responses in human primary macrophages: a systems approach.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 29, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Nanoparticles targeting the infarcted heart.

Tal Dvir1, Michael Bauer, Avi Schroeder

  • 1Department of Chemical Engineering, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.

Nano Letters
|September 9, 2011
PubMed
Summary
This summary is machine-generated.

Researchers developed targeted nanoparticles for the heart after myocardial infarction (MI). These liposomes bind to the angiotensin II type 1 (AT1) receptor, enabling targeted delivery to cardiac cells in vitro and in vivo.

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in G&#246;ttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in G&#246;ttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cardiovascular Research

Background:

  • Myocardial infarction (MI) leads to significant cardiac damage.
  • Targeted drug delivery to the infarcted heart remains a challenge.
  • Overexpression of angiotensin II type 1 (AT1) receptors occurs in infarcted cardiac tissue.

Purpose of the Study:

  • To develop and evaluate a nanoparticulate system for targeted delivery to the infarcted heart.
  • To utilize the AT1 receptor as a specific target in cardiac tissue post-MI.
  • To assess the targeting efficiency of the nanoparticles in vitro and in vivo.

Main Methods:

  • Conjugation of AT1 receptor-specific ligands to 142 nm liposomes.
  • In vitro testing of nanoparticle targeting to cardiac cells.
  • In vivo intravenous administration and assessment of nanoparticle distribution in an MI model.

Main Results:

  • Nanoparticles demonstrated specific targeting of cardiac cells in vitro.
  • In vivo studies confirmed specific accumulation of nanoparticles in the infarcted heart.
  • The developed liposomal system showed effective targeting after intravenous injection.

Conclusions:

  • A novel nanoparticulate system effectively targets the infarcted heart.
  • Targeting is mediated by the overexpression of AT1 receptors in cardiac tissue post-MI.
  • This system holds potential for targeted therapeutic agent delivery to the heart.